Effects of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight: A Meta-Analysis

Glucagon-Like Peptide-1 receptor agonists (GLP-1RAs), approved as glucose-lowering drugs for the treatment of type 2 diabetes, have also been shown to reduce body weight. An extensive Medline, Cochrane database, and Embase search for “exenatide,” “liraglutide,” “albiglutide,” “semaglutide,” and “lix...

Full description

Saved in:
Bibliographic Details
Main Authors: Monami, Matteo, Dicembrini, Ilaria, Marchionni, Niccolò, Rotella, Carlo M., Mannucci, Edoardo
Format: Artigo
Language:Inglês
Published: Hindawi Publishing Corporation 2012
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3362858/
https://ncbi.nlm.nih.gov/pubmed/22675341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/672658
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items